DoH NI MEDICINES ACCESS REVIEW — RECOMMENDATION 2
The DoH NI Medicines Access Review (2025) specifically names the Blueteq HCD system as the recommended replacement for cost-per-case commissioning.
The DoH NI Medicines Access Review (2025) specifically names the Blueteq HCD system as the recommended replacement for cost-per-case commissioning.
Governance that prevents recurrence: every high-cost prescription requires documented eligibility confirmation before treatment.
Unit A5, Endeavour Business Park
Penner Road, Havant
PO9 1QN
Company Registration Number: 5334133
Company VAT Number: 855 7246 95
© 2026 Blueteq Ltd
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.